Steven Harris, MD
Urology · Long Beach, NYNPI 1861474918
Payments from drug & device makers
Across 40 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$154
- Astellas Pharma US Inc$116
- Dendreon Pharmaceuticals LLC$106
- Bayer$93
- Ferring Pharmaceuticals Inc.$79
- Myovant Sciences Inc.$54
- plus $271 from 11 others
What the payments were for
- Food & beverage$83896%
- Education$354%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $154 |
| Astellas Pharma US Inc | 6 | $116 |
| Dendreon Pharmaceuticals LLC | 4 | $106 |
| Bayer | 2 | $93 |
| Ferring Pharmaceuticals Inc. | 4 | $79 |
| Myovant Sciences Inc. | 2 | $54 |
| Endo Pharmaceuticals Inc. | 2 | $41 |
| Neotract Inc. | 2 | $40 |
| AstraZeneca | 1 | $35 |
| Blue Earth Diagnostics | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Cook Medical LLC | 1 | $19 |
| AbbVie | 1 | $18 |
| Dentsply IH Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Boston Scientific | 1 | $14 |
| Pfizer | 1 | $14 |
How this compares
$873 in reported general payments places this provider in the 30th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 377 | $4,813 |
| Finasteride | 235 | $3,250 |
| Solifenacin Succinate | 17 | $3,002 |
| Oxybutynin Chloride ErOxybutynin Chloride | 80 | $2,088 |
| Tolterodine Tartrate ErTolterodine Tartrate | 25 | $1,475 |
| Methenamine Hippurate | 13 | $1,419 |
| Imipramine Hcl | 27 | $1,085 |
| Dutasteride | 12 | $1,041 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 37 | $606 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 17 | $372 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $266 |
| Fluconazole | 33 | $251 |
| Allopurinol | 21 | $245 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 73 | $191 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $163 |
Paid to pharmacies, not to this prescriber.
Other urology in Long Beach
- Christopher PieczonkaSyracuse$31.2M
- Guarionex DecastroNew York$5.7M
- Mitchell EfrosGarden City$4.2M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Jed KaminetskyMiddle Village$3.5M
- Evan GoldfischerPoughkeepsie$3.1M
- Gennady BratslavskySyracuse$2.5M
- Ashutosh TewariNew York$2.5M
- Manish ViraNew Hyde Park$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.